Publication Name	World Journal of Hepatology
Manuscript ID	34317
Country	United States

Received	2017-04-14 08:21
Peer-Review Started	2017-04-14 17:24
To Make the First Decision	2017-05-08 09:26
Return for Revision	2017-05-09 17:20
Revised	2017-05-11 02:31
Second Decision	2017-05-24 01:32
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-05-31 02:55
Articles in Press	2017-05-31 02:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-07-07 01:16
Publish the Manuscript Online	2017-07-17 23:13

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Changing landscape of hepatitis C virus-positive donors
Manuscript Source	Unsolicited Manuscript
All Author List	Catherine E Kling, Ajit P Limaye and Lena Sibulesky
Funding Agency and Grant Number
Corresponding Author	Lena Sibulesky, MD, Assistant Professor, Division of Transplant Surgery, Department of Surgery, University of Washington Medical Center, 1959 NE Pacific Street, Box 356410, Seattle, WA98195, United States. lenasi@uw.edu
Key Words	Heptitis C organ utilization; Hepatitis C virus aviremic; Liver transplantation; Hepatitis C positive recipients
Core Tip	For many years hepatitis C virus (HCV) positive livers have been used with caution in carefully selected mostly HCV-positive patients. With the introduction of the new highly effective antiviral therapies discard rate of HCV-positive livers, although improved, continues to be high. On August 10, 2015, the United Network for Organ Sharing mandated all Organ Procurement Organizations to perform and report HCV Nucleic Acid Amplification Testing (NAT) results on all deceased and living donors. We believe further research in the outcome of viremic and aviremic HCV livers is needed so that the utilization of these organs can be maximized in HCV NAT + and potentially HCV NAT - recipients.
Publish Date	2017-07-17 23:13
Citation	Kling CE, Limaye AP, Sibulesky L. Changing landscape of hepatitis C virus-positive donors. World J Hepatol 2017; 9(20): 905-906
URL	http://www.wjgnet.com/1948-5182/full/v9/i20/905.htm
DOI	http://dx.doi.org/10.4254/wjh.v9.i20.905

Full Article (PDF)	WJH-9-905.pdf
Full Article (Word)	WJH-9-905.doc
Manuscript File	34317-Review.docx
Answering Reviewers	34317-Answering reviewers.pdf
Audio Core Tip	34317-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	34317-Conflict-of-interest statement.pdf
Copyright License Agreement	34317-Copyright assignment.pdf
Peer-review Report	34317-Peer-review(s).pdf
Scientific Misconduct Check	34317-Scientific misconduct check.pdf
Scientific Editor Work List	34317-Scientific editor work list.pdf